Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Aimmune Therapeutics, Inc. (AIMT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 0% stake in Aimmune Therapeutics, Inc. |
| 02/12/2020 |
SC 13G/A
| Longitude Capital Partners II, LLC reports a 9.8% stake in Aimmune Therapeutics, Inc. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 5.8% stake in AIMMUNE THERAPEUTICS, INC |
| 02/13/2019 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 5.9% stake in Aimmune Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Longitude Capital Partners II, LLC reports a 10% stake in Aimmune Therapeutics, Inc. |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 7.6% stake in Aimmune Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2018 |
SC 13G/A
| AISLING CAPITAL III LP reports a 4.4% stake in Aimmune Therapeutics, Inc. |
| 02/21/2017 |
SC 13G/A
| Longitude Capital Partners II, LLC reports a 14.4% stake in Aimmune Therapeutics, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Aimmune Therapeutics, Inc. reports a 9.5% stake in Aimmune Therapeutics, Inc. |
| 02/10/2017 |
SC 13G/A
| Aimmune Therapeutics, Inc. reports a 14.4% stake in Aimmune Therapeutics, Inc. |
| 01/18/2017 |
SC 13G/A
| Explore Holdings LLC reports a 2% stake in Aimmune Therapeutics, Inc. |
| 12/12/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|